LOGIN BECOME A MEMBER
×
×

JEADV ARTICLES

In line with the ongoing international research efforts to understand COVID-19, JEADV is committed to disseminating relevant and practical information for healthcare providers and patients. We are focusing on the implications of the novel coronavirus for dermatology and venereology. All featured articles in the JEADV COVID-19 Special Forum are freely available online.

 

JEADV COVID-19 Special Forum

Categories: Guidelines and recommendations

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C



J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411.

Categories: Guidelines and recommendations

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.



J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557.

Categories: Guidelines and recommendations

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.



J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525.

Categories: Guidelines and recommendations

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.



J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID‐19: a first perspective.

Recalcati, S.



J Eur Acad Dermatol Venereol. 2020 Mar 26. doi: 10.1111/jdv.16387.

Categories: Cutaneous manifestations of COVID-19

Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16470.

Categories: Cutaneous manifestations of COVID-19

Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S.

Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M.



J Eur Acad Dermatol Venereol. 2020 Apr 21. doi: 10.1111/jdv.16519.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID-19: a new contribution.

Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16474.

Categories: Cutaneous manifestations of COVID-19

COVID-19 and cutaneous manifestations.

Mungmungpuntipantip R, Wiwanitkit V.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16483.

Categories: Cutaneous manifestations of COVID-19

A distinctive skin rash associated with Coronavirus Disease 2019?

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16471.

Categories: Cutaneous manifestations of COVID-19

Urticarial eruption in COVID-19 infection.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16472.

Categories: Cutaneous manifestations of COVID-19

Viral exanthem in COVID-19, a clinical enigma with biological significance.

Su CJ, Lee CH.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16469.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestation of COVID-19 in images: A case report.

Avellana Moreno R, Villa E, Avellana Moreno V, Estela Villa C, Aparicio M, Fontanella A.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16531.

Categories: Cutaneous manifestations of COVID-19

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.

Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16530.

Categories: Cutaneous manifestations of COVID-19

Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.

van Damme C, Berlingin E, Saussez S, Accaputo O.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16523.

Categories: Cutaneous manifestations of COVID-19

Did Whatsapp® reveal a new cutaneous COVID-19 manifestation?

Duong TA, Velter C, Rybojad M, Comte C, Bagot M, Sulimovic L, Bouaziz JD.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16534.

Categories: Cutaneous manifestations of COVID-19

Acral cutaneous lesions in the time of COVID-19.

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16533.

Categories: Cutaneous manifestations of COVID-19

SARS-CoV-2 infection presenting as a febrile rash.

Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16528.

Categories: Cutaneous manifestations of COVID-19

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16526.

Categories: Cutaneous manifestations of COVID-19

Symmetric cutaneous vasculitis in COVID-19 pneumonia.

Castelnovo L, Capelli F, Tamburello A, Maria Faggioli P, Mazzone A.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16589.

Categories: Cutaneous manifestations of COVID-19

Vascular skin symptoms in COVID-19: a french observational study.

Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M.



J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16544.

Categories: Cutaneous manifestations of COVID-19

Histological pattern in Covid-19 induced viral rash.

Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, Patrizi A, Gaspari V.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16569.

Categories: Cutaneous manifestations of COVID-19

Acro-ischemia in hospitalized COVID-19 patients.

Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16592.

Categories: Cutaneous manifestations of COVID-19

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.

Ehsani AH, Nasimi M, Bigdelo Z.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16579.

Categories: Cutaneous manifestations of COVID-19

The use of Google trends for acral symptoms during COVID-19 outbreak in France.

Kluger N, Scrivener Y.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16572.

Categories: Cutaneous manifestations of COVID-19

Drug-induced vasculitis in a patient with COVID-19.

Ramirez AV, Efe D, Fischer M.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16588.

Categories: Cutaneous manifestations of COVID-19

A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?

Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza C.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16633.

Categories: Cutaneous manifestations of COVID-19

Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.

Janah H, Zinebi A, Elbenaye J.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16623.

Categories: Cutaneous manifestations of COVID-19

Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia.

Gunawan C, Angela, Widysanto A.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16622. 

Categories: Cutaneous manifestations of COVID-19

A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.

Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, Pérez-González Y.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16631.

Categories: Cutaneous manifestations of COVID-19

Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.

Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, Sena P.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16613. 

Categories: Cutaneous manifestations of COVID-19

Reply to "Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection": Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation.

Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16618.

Categories: Cutaneous manifestations of COVID-19

Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient.

Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16617. 

Categories: Cutaneous manifestations of COVID-19

Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16636.

Categories: Biologics and immunomodulatory therapies

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Di Altobrando A, Patrizi A, Bardazzi F.



J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16491.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina F, Piaserico S.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16468.

Categories: Biologics and immunomodulatory therapies

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.

Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S.



J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16527.

Categories: Biologics and immunomodulatory therapies

No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.

Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P.



J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16552.

Categories: Biologics and immunomodulatory therapies

"Toxic Erythema" and Eosinophilia Associated to Tocilizumab Therapy in a COVID-19 Patient

Sernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16620.

Categories: Biologics and immunomodulatory therapies

Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs.

Conti A, Lasagni C, Bigi L, Pellacani G.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16587.

Categories: Biologics and immunomodulatory therapies

Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patient.

Benhadou F, Del Marmol V.



J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16590. 

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.

Caroppo F, Biolo G, Belloni Fortina A.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16619.

Categories: Biologics and immunomodulatory therapies

SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.

Balestri R, Rech G, Girardelli CR.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16571.

Categories: Clinical set-up and service delivery

What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China.

Zhang H, Tang K, Fang R, Sun Q.



J Eur Acad Dermatol Venereol. 2020 Mar 27. doi: 10.1111/jdv.16389.

Categories: Clinical set-up and service delivery

Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.

Radi G, Diotallevi F, Campanati A, Offidani A.



J Eur Acad Dermatol Venereol. 2020 Mar 22. doi: 10.1111/jdv.16386.

Categories: Clinical set-up and service delivery

Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day!

Jakhar D, Kaur I, Kaul S.



J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16412.

Categories: Clinical set-up and service delivery

Face the COVID-19 emergency: measures applied in an Italian dermatologic clinic.

Marasca C, Ruggiero A, Annunziata MC, Fabbrocini G, Megna M.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16476.

Categories: Clinical set-up and service delivery

Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.

Gisondi P, Piaserico S, Conti A, Naldi L.



J Eur Acad Dermatol Venereol. 2020 Apr 22. doi: 10.1111/jdv.16515.

Categories: Clinical set-up and service delivery

Changes in emergency service access after spread of COVID19 across Italy

Tartari F, Guglielmo A, Fuligni F, Pileri A.



J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16553.

Categories: Clinical set-up and service delivery

COVID-19 and dermatology: A comprehensive guide for dermatologists.

Fahmy DH, El-Amawy HS, El-Samongy MA, Foud AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16545. 

Categories: Clinical set-up and service delivery

Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of literature.

Campanati A, Brisigotti V, Diotallevi F, D'Agostino GM, Paolinelli M, Radi G, Rizzetto G, Sapigni C, Tagliati C, Offidani A.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16646.

Categories: Clinical set-up and service delivery

Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?

Skayem C, Cassius C, Ben Kahla M, Fiani C, Frumholtz L, Mrad M, Petit A, Zuelgaray E, Bagot M, Bouaziz JD, Duong TA.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16630.

Categories: Ocupational skin disease, including effects of PPE

Dermatology staff participate in fight against Covid-19 in China.

Zheng Y, Lai W.



J Eur Acad Dermatol Venereol. 2020 Mar 23. doi: 10.1111/jdv.16390.

Categories: Ocupational skin disease, including effects of PPE

Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemic.

Gheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S.



J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16492.

Categories: Ocupational skin disease, including effects of PPE

Covid-19: Countermeasure for N95 mask-induced pressure sore.

Yin Z.



J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16490.

Categories: Ocupational skin disease, including effects of PPE

Hand disinfection in the combat against Covid-19.

Goldust M, Abdelmaksoud A, Navarini AA.



J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16574.

Categories: Ocupational skin disease, including effects of PPE

COVID-19 epidemic: Skin protection for health care workers must not be ignored.

Zhang B, Zhai R, Ma L.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16573.

Categories: Ocupational skin disease, including effects of PPE

Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients.

Pei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M.



J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16570.

Categories: Ocupational skin disease, including effects of PPE

Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic.

Campbell V, Middleton D, Donnelly J, Hunter H.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16624. 

Categories: Ocupational skin disease, including effects of PPE

Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases.

Singh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A.



J Eur Acad Dermatol Venereol. 2020 May 12. doi: 10.1111/jdv.16628. 

Categories: Ocupational skin disease, including effects of PPE

Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study.

Dong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J.



J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16638.

Categories: Specific diseases and patient groups

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C



J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411.

Categories: Specific diseases and patient groups

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.



J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525.

Categories: Specific diseases and patient groups

Skin cancer triage and management during COVID-19 pandemic.

Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB).



J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16529.

Categories: Specific diseases and patient groups

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16473.

Categories: Specific diseases and patient groups

Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model.

Tejera-Vaquerizo A, Nagore E.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16555.

Categories: Specific diseases and patient groups

Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.

Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT.



J Eur Acad Dermatol Venereol. 2020 May 19. doi: 10.1111/jdv.16586.

Categories: Specific diseases and patient groups

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.



J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557.

Categories: Specific diseases and patient groups

Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.

Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.



J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593.

Categories: Specific diseases and patient groups

Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.

Balestri R, Rech G, Girardelli CR.



J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16578.

Categories: Specific diseases and patient groups

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.



J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16625.